Financial Performance

A USA Today feature highlights Nex-Tech’s rural fiber expansion, but the real story is how a Kansas cooperative built a nationwide enterprise tech empire.

Starfighters Space claims its vintage jets can solve the hypersonic testing bottleneck. A deep dive into the financials reveals a more complicated reality.

Asahi Kasei Therapeutics begins Phase 2a trials for AIC468, a pioneering RNA-splicing therapy aiming to solve a critical kidney transplant dilemma.

BridgeBio is using cultural icons to find undiagnosed heart disease in Black men. It’s a brilliant public health move—and a shrewd business strategy.

St. Luke's $252 million cardiovascular facility isn't just a hospital—it is a highly networked, data-driven node reshaping regional healthcare infrastructure.

Despite spending millions, large European enterprises are missing GDPR data access deadlines as generative AI tools create unprecedented compliance bottlenecks.

Ottawa announces a $192,000 grant for the Indigenous Performing Arts Alliance, but looming budget cuts raise questions about long-term reconciliation efforts.

MiNK Therapeutics reveals new preclinical data on off-the-shelf iNKT therapies, targeting treatment-resistant colorectal cancer and senescent tumor cells.

By trading toxic payloads for precise degradation, Nurix Therapeutics is writing a masterclass in biotech survival and post-merger pharmaceutical strategy.

Etruscus Resources’ latest financing reveals the high-stakes financial and geological maneuvering driving junior exploration in BC's Golden Triangle.

Following a $500 million capital campaign and a blockbuster July 4 opening, the Theodore Roosevelt Presidential Library is rewriting the business of historical tourism.

A billionaire's private school is funneling students directly into his HVAC empire. Is it a bold workforce solution or corporate overreach?

GridStor’s $220 million financing for the White Tank battery project highlights how institutional capital is solving Arizona's tech-driven energy crunch.

A $5 billion plan promises free AI supercomputers for Korean merchants. But who really pays for this speculative edge-computing network?

With standard-of-care avacopan facing global regulatory withdrawal, InflaRx is stepping into the void. A strategic look at the upcoming Capital Markets Day and the mechanics of clinical resilience.

As the 2026 World Manufacturing Convention opens, Hefei showcases quantum leaps and a $56B deal pipeline. But can the 'Hefei Model' sustain this momentum?

As country music expands its footprint in Los Angeles, celebrity-driven philanthropy is quietly becoming the lifeblood of public school arts education.

Beneath the surface of Beneva's new five-year title sponsorship lies a strategic masterclass in corporate expansion, risk mitigation, and community building.

As Silicon Valley Bank prepares to shed its iconic name, a new CB Insights partnership equips founders with institutional AI tools to defend its market share.

Regent Park's Building 4A just won a major international design award. But the real story is the complex capital stack and social leverage driving Canada's most ambitious urban revitalization.